Scinai Immunotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1.66	1.96	4.87	14.08	17.37
Cash & Short-Term Investments	1.66	1.96	4.87	14.08	17.37
Cash Growth	-15.43%	-59.67%	-65.40%	-18.99%	492.87%
Accounts Receivable	0.07	0.08	-	-	-
Other Receivables	0.1	0.13	0.37	0.11	0.1
Receivables	0.17	0.22	0.37	0.11	0.1
Prepaid Expenses	0.08	0.08	0.07	0.05	0.23
Restricted Cash	0.15	0.13	0.14	0.14	0.14
Total Current Assets	2.05	2.39	5.45	14.37	17.84
Property, Plant & Equipment	9.57	11.06	12.03	12.7	14.19
Total Assets	11.63	13.45	17.47	27.07	32.04
Accounts Payable	0.41	0.38	0.54	0.72	1
Accrued Expenses	0.76	0.78	0.85	1.24	1.07
Current Portion of Leases	0.33	0.42	0.4	0.38	0.38
Current Unearned Revenue	0.09	0.23	-	-	-
Total Current Liabilities	1.59	1.81	1.78	2.34	2.44
Long-Term Debt	0.29	0.26	19.37	20.08	27.16
Long-Term Leases	1.64	1.4	0.8	1.08	1.45
Other Long-Term Liabilities	-	0	0.1	5.33	-
Total Liabilities	3.52	3.47	22.04	28.83	31.05
Additional Paid-In Capital	130.06	123.63	119.51	116.08	113.08
Retained Earnings	-125.85	-117.54	-122.34	-115.84	-110.04
Comprehensive Income & Other	-1.74	-1.74	-1.74	-2.01	-2.06
Total Common Equity	2.48	4.35	-4.57	-1.76	0.98
Shareholders' Equity	8.1	9.98	-4.57	-1.76	0.98
Total Liabilities & Equity	11.63	13.45	17.47	27.07	32.04
Total Debt	2.27	2.09	20.56	21.54	28.99
Net Cash (Debt)	-0.61	-0.12	-15.69	-7.47	-11.61
Net Cash Per Share	-0.26	-0.15	-40.17	-39.61	-82.26
Filing Date Shares Outstanding	3.47	0.85	0.46	0.33	0.19
Total Common Shares Outstanding	3.47	0.85	0.46	0.33	0.19
Working Capital	0.47	0.59	3.67	12.03	15.4
Book Value Per Share	0.71	5.10	-9.84	-5.36	5.22
Tangible Book Value	2.48	4.35	-4.57	-1.76	0.98
Tangible Book Value Per Share	0.71	5.10	-9.84	-5.36	5.22
Machinery	9.95	9.92	2.46	1.92	1.23
Construction In Progress	-	-	7.45	7.83	8.86
Leasehold Improvements	3.72	3.72	3.72	3.92	4.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.